Global Micro-Positron Emission Tomography (PET) Systems Market, By Applications (Cardiology, Neurology, Oncology, Orthopedics, Urology, Gastroenterology, Others), End User (Hospitals, Clinics, Diagnostic Centers, Others) – Industry Trends and Forecast to 2029.
Market Analysis and Size
In recent years, micro- positron emission tomography (PET) systems have been highly utilized in both the medical and research fields. These systems are used along with magnetic resonance imaging (MRI) scans and computed tomography (CT) for diagnosing epilepsy, coronary artery disease, lung cancer and Alzheimer's disease, among others.
Global Micro- Positron Emission Tomography (PET) Systems Market was valued at USD 975 million in 2021 and is expected to reach USD 1440.52 million by 2029, registering a CAGR of 5.00% during the forecast period of 2022-2029. “Hospitals” accounts for the most prominent end user segment in the respective market owing to the rise in the number of cancer cases. The market report curated by DBMR research team includes in-depth expert analysis, patient epidemiology, pipeline analysis, pricing analysis, and regulatory framework.
Market Definition
Micro-positron emission tomography (PET) refers to a combination of nuclear medicine and biochemical analysis is utilized for measuring the metabolic activity of cells. This combination is administered a small amount of radioactive glucose (sugar) into the patient’s vein through an intravenous (IV) line. Detailed pictures of areas containing the glucose is generated with the assistance of a scanner and computer. PET is used for early detection of heart diseases, brain disorders and cancer.
Report Scope and Market Segmentation
|
Report Metric
|
Details
|
|
Forecast Period
|
2022 to 2029
|
|
Base Year
|
2021
|
|
Historic Years
|
2020 (Customizable to 2019 - 2014)
|
|
Quantitative Units
|
Revenue in USD Million, Volumes in Units, Pricing in USD
|
|
Segments Covered
|
Applications (Cardiology, Neurology, Oncology, Orthopedics, Urology, Gastroenterology, Others), End User (Hospitals, Clinics, Diagnostic Centers, Others)
|
|
Countries Covered
|
U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
|
|
Market Players Covered
|
Positron Corporation (US), CellSight Technologies. (US), RefleXion. (Canada), Clarity Pharmaceuticals (Australia), PETsys Electronics SA (Portugal), Blue Earth Diagnostics Limited. (UK), Qubiotech Health Intelligence S.L. (Spain), Advanced Accelerator Applications (France), Lily. (US), Agfa-Gevaert Group. (Belgium), CMR Naviscan. (US), Neusoft Corporation (China), Siemens (Germany), Segamicorp (US), ONCOVISION. (Spain), MedX Holdings, Inc (US), Modus Medical Devices Inc. (Canada), Radiology Oncology Systems (US), TOSHIBA CORPORATION (Japan), and General Electric Company (US), among others
|
|
Market Opportunities
|
|
Micro-Positron Emission Tomography (PET) Systems Market Dynamics
This section deals with understanding the market drivers, advantages, opportunities, restraints and challenges. All of this is discussed in detail as below:
- Prevalence of Cancer
The increase in the prevalence of cancer acts as one of the major factors driving the growth micro- positron emission tomography (PET) systems market. With the increase in the cases of cancer, the demand for enhanced diagnostics and treatment is rising.
- Continuous Support for Cancer Research
The continuous support for cancer research from the public and private sectors in the form of funds and investments accelerate the market growth.
- Research and Development
The surge in the number of research and development activities to enhance the treatment options available further influence the market. The advancement in the technology declines the acquisition time and offers high sensitivity and specifity.
Opportunities
Furthermore, popularity of the hybrid imaging systems extend profitable opportunities to the market players in the forecast period of 2022 to 2029. Also, technological development will further expand the market.
Restraints/Challenges
On the other hand, stringent regulatory rules are expected to obstruct market growth. Also, high cost associated with the scanners is projected to challenge the micro-positron emission tomography (PET) systems market in the forecast period of 2022-2029.
This micro-positron emission tomography (PET) systems market report provides details of new recent developments, trade regulations, import-export analysis, production analysis, value chain optimization, market share, impact of domestic and localized market players, analyses opportunities in terms of emerging revenue pockets, changes in market regulations, strategic market growth analysis, market size, category market growths, application niches and dominance, product approvals, product launches, geographic expansions, technological innovations in the market. To gain more info on micro-positron emission tomography (PET) systems market contact Data Bridge Market Research for an Analyst Brief, our team will help you take an informed market decision to achieve market growth.
Covid-19 Impact on Micro-Positron Emission Tomography (PET) Systems Market
COVID-19 had both positive and negative impact on the micro- positron emission tomography (PET) systems market. The decline in the productivity in life science organizations during the pandemic impacted the market. However, PET emerged as a great potential in the improvement and management of COVID-19 that accelerated the demand for micro- positron emission tomography (PET) systems. The market is expected to witness health growth post-pandemic as well owing to its application in combating various other epidemics in the future.
Recent Development
- Siemens Healthineers announced the news of FDA clearance for Biograph Vision Quadra PET/CT Scanner in March’2021. The product is specifically for clinical use and translational research-or the application of scientific research for creating procedures and therapies that enhance health outcomes.
Global Micro-Positron Emission Tomography (PET) Systems Market Scope and Market Size
The micro-positron emission tomography (PET) systems market is segmented on the basis of applications and end user. The growth amongst these segments will help you analyze meager growth segments in the industries and provide the users with a valuable market overview and market insights to help them make strategic decisions for identifying core market applications.
Applications
- Cardiology
- Neurology
- Oncology
- Orthopedics
- Urology
- Gastroenterology
- Others
On the basis of applications, the micro-positron emission tomography (PET) systems market is segmented into cardiology, neurology, oncology, orthopedics, urology, gastroenterology and others.
End User
- Hospitals
- Clinics
- Diagnostic Centers
- Others
On the basis of end user, the micro-positron emission tomography (PET) systems market is segmented into hospitals, clinics, diagnostic centers and others.
Micro-Positron Emission Tomography (PET) Systems Market Regional Analysis/Insights
The micro-positron emission tomography (PET) systems market is analysed and market size insights and trends are provided by country, applications and end user as referenced above.
The countries covered in the micro-positron emission tomography (PET) systems market report are U.S., Canada and Mexico in North America, Germany, France, U.K., Netherlands, Switzerland, Belgium, Russia, Italy, Spain, Turkey, Rest of Europe in Europe, China, Japan, India, South Korea, Singapore, Malaysia, Australia, Thailand, Indonesia, Philippines, Rest of Asia-Pacific (APAC) in the Asia-Pacific (APAC), Saudi Arabia, U.A.E, South Africa, Egypt, Israel, Rest of Middle East and Africa (MEA) as a part of Middle East and Africa (MEA), Brazil, Argentina and Rest of South America as part of South America.
North America dominates the micro-positron emission tomography (PET) systems market because of the increased risks in patients with cardiovascular disease and cancer within the region.
Asia-Pacific (APAC) is expected to witness significant growth during the forecast period of 2022 to 2029 due to the large patient population in the region.
The country section of the report also provides individual market impacting factors and changes in regulation in the market domestically that impacts the current and future trends of the market. Data points like down-stream and upstream value chain analysis, technical trends and porter's five forces analysis, case studies are some of the pointers used to forecast the market scenario for individual countries. Also, the presence and availability of global brands and their challenges faced due to large or scarce competition from local and domestic brands, impact of domestic tariffs and trade routes are considered while providing forecast analysis of the country data.
Healthcare Infrastructure growth Installed base and New Technology Penetration
The micro-positron emission tomography (PET) systems market also provides you with detailed market analysis for every country growth in healthcare expenditure for capital equipment, installed base of different kind of products for micro-positron emission tomography (PET) systems market, impact of technology using life line curves and changes in healthcare regulatory scenarios and their impact on the micro-positron emission tomography (PET) systems market. The data is available for historic period 2010-2020.
Competitive Landscape and Micro-Positron Emission Tomography (PET) Systems Market Share Analysis
The micro-positron emission tomography (PET) systems market competitive landscape provides details by competitor. Details included are company overview, company financials, revenue generated, market potential, investment in research and development, new market initiatives, global presence, production sites and facilities, production capacities, company strengths and weaknesses, product launch, product width and breadth, application dominance. The above data points provided are only related to the companies' focus related to micro-positron emission tomography (PET) systems market.
Some of the major players operating in the micro-positron emission tomography (PET) systems market are
- Positron Corporation (US)
- CellSight Technologies. (US)
- RefleXion. (Canada)
- Clarity Pharmaceuticals (Australia)
- PETsys Electronics SA (Portugal)
- Blue Earth Diagnostics Limited. (UK)
- Qubiotech Health Intelligence S.L. (Spain)
- Advanced Accelerator Applications (France)
- Lily. (US)
- Agfa-Gevaert Group. (Belgium)
- CMR Naviscan. (US)
- Neusoft Corporation (China)
- Siemens (Germany)
- Segamicorp (US)
- ONCOVISION. (Spain)
- MedX Holdings, Inc (US)
- Modus Medical Devices Inc. (Canada)
- Radiology Oncology Systems (US)
- TOSHIBA CORPORATION (Japan)
- General Electric Company (US)
SKU-